RoyceDerm Eczema Relief Cream
- Manufacturer
- RoyceDerm LLC
- Effective date
- 2025-09-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:15:04
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Colloidal Oatmeal 1%
OTC - PURPOSE SECTION
Skin Protectant
DOSAGE & ADMINISTRATION SECTION
Temporarily protects and helps relieve minor skin irritationand itching due to Eczema and Rashes
WARNINGS SECTION
For external use only
OTC - WHEN USING SECTION
do not get into eyes
OTC - ASK DOCTOR SECTION
condition worsens or symptoms last morethan 7 days or clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Centerright away.(1-800-222-1222)
INDICATIONS & USAGE SECTION
- Conduct a patch test on a small area of skin to checkfor sensitivity or allergic reaction.
- Apply as needed to affectedarea.
- Use 1-2 times daily or as directed by a doctor.
- For childrenunder 6 months of age: ask a doctor.
OTHER SAFETY INFORMATION
store at room temperature. Avoid excessive heat and direct sunlight.
INACTIVE INGREDIENT SECTION
Aqua, Butylene Glycol, Glycerin, Simmondsia Chinensis (Jojoba) Seed Oil, Squalane, Camellia Japonica Seed Oil,Cetearyl Alcohol, Butyrospermum Parkii (Shea Butter), Tocopheryl Acetate, Cetearyl Glucoside, Panthenol, 1,2-Hexanediol, Hydroxyacetophenone, Ceramide 1, Ceramide 3, Ceramide 6 ll, Ectoin,Carboxymethyl Chitosan, Camellia Sinensis Leaf Extract, Tremella Fuciformis Polysaccharide, Avena Sativa (Oat) Kernel Extract, Aloe Barbadensis Leaf Extract, Portulaca Oleracea Extract, Maltodex-trin, Chrysanthellum Indicum Extract, Houttuynia Cordata ExtractOpuntia Streptacantha Stem Extract, Scutellaria Baicalensis Root Extract, Paeonia Suffruticosa Root Extract, Allantoin, Sodium Hyaluronate, Sodium Polyglutamate, Centella Asiatica Extract, Madecassoside, Asiaticoside
OTC - QUESTIONS SECTION
Email service@roycederm.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| OATMEAL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85424-010-01 | RoyceDerm Eczema Relief Cream | 113 g in 1 CARTON | CREAM | 113 | 1 |
Products#
Every source-derived product name is available through these pages.
- RoyceDerm Eczema Relief Cream
- Colloidal Oatmeal 1%
- AQUA
- GLYCERIN
- BUTYLENE GLYCOL
- .ALPHA.-TOCOPHEROL ACETATE, D-
- BUTYROSPERMUM PARKII (SHEA) BUTTER
- HYDROXYACETOPHENONE
- ASIATICOSIDE
- ALOE BARBADENSIS LEAF
- CHRYSANTHELLUM INDICUM TOP
- ECTOIN
- MALTODEXTRIN
- CETEARYL GLUCOSIDE
- PANTHENOL
- HOUTTUYNIA CORDATA FLOWERING TOP
- CENTELLA ASIATICA TRITERPENOIDS
- OAT
- OATMEAL
- N-CARBOXYMETHYLCHITOSAN
- CERAMIDE 6 II
- PURSLANE
- PAEONIA SUFFRUTICOSA ROOT
- SODIUM POLYGLUTAMATE (200000 MW)
- MADECASSOSIDE
- CAMELLIA SINENSIS LEAF
- SODIUM HYALURONATE
- CETEARYL ALCOHOL
- SQUALANE
- CAMELLIA JAPONICA SEED OIL
- SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL
- OPUNTIA STREPTACANTHA STEM
- 1,2-HEXANEDIOL
- CERAMIDE 1
- TREMELLA FUCIFORMIS WHOLE
- SCUTELLARIA BAICALENSIS ROOT
- ALLANTOIN
- CERAMIDE 3
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85424-010 | 85424-010-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RoyceDerm Eczema Relief Cream | COLLOIDAL OATMEAL 1% | RoyceDerm LLC | 3e09f000-01d2-0d21-e063-6294a90ac548 | 2025-09-05 | Warnings | 85424-010-01 85424-010 85424001001 3e09f000-01d3-0d21-e063-6294a90ac548 3e09f000-01d2-0d21-e063-6294a90ac548 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
